| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.006 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.73 | 0.007 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.08 | 0.008 |